JP2020152698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020152698A5 JP2020152698A5 JP2019054780A JP2019054780A JP2020152698A5 JP 2020152698 A5 JP2020152698 A5 JP 2020152698A5 JP 2019054780 A JP2019054780 A JP 2019054780A JP 2019054780 A JP2019054780 A JP 2019054780A JP 2020152698 A5 JP2020152698 A5 JP 2020152698A5
- Authority
- JP
- Japan
- Prior art keywords
- stem cells
- mesenchymal stem
- osteoarthritis
- joint
- umbilical cord
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000008482 osteoarthritis Diseases 0.000 claims description 38
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 27
- 208000012659 Joint disease Diseases 0.000 claims description 5
- 210000001808 exosome Anatomy 0.000 claims description 4
- 210000003954 umbilical cord Anatomy 0.000 claims description 3
- 206010034464 Periarthritis Diseases 0.000 claims description 2
- 210000001264 anterior cruciate ligament Anatomy 0.000 claims description 2
- 210000001188 articular cartilage Anatomy 0.000 claims description 2
- 230000001684 chronic effect Effects 0.000 claims description 2
- 230000006378 damage Effects 0.000 claims description 2
- 210000004700 fetal blood Anatomy 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
- 230000032683 aging Effects 0.000 claims 1
- 210000004381 amniotic fluid Anatomy 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 230000003169 placental effect Effects 0.000 claims 1
- 238000011282 treatment Methods 0.000 description 12
- 210000000130 stem cell Anatomy 0.000 description 8
- 210000000845 cartilage Anatomy 0.000 description 7
- 210000001612 chondrocyte Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 238000009168 stem cell therapy Methods 0.000 description 5
- 238000009580 stem-cell therapy Methods 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 210000002865 immune cell Anatomy 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000001665 muscle stem cell Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- SLUINPGXGFUMLL-UHFFFAOYSA-N 2-[(4-phenylphenyl)carbamoyl]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(=O)NC1=CC=C(C=2C=CC=CC=2)C=C1 SLUINPGXGFUMLL-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 210000005258 dental pulp stem cell Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 230000003349 osteoarthritic effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 102000016284 Aggrecans Human genes 0.000 description 1
- 108010067219 Aggrecans Proteins 0.000 description 1
- 208000025674 Anterior Cruciate Ligament injury Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010007710 Cartilage injury Diseases 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 206010061762 Chondropathy Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 101001010626 Homo sapiens Interleukin-22 Proteins 0.000 description 1
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 1
- -1 IL1β Proteins 0.000 description 1
- 102000004125 Interleukin-1alpha Human genes 0.000 description 1
- 108010082786 Interleukin-1alpha Proteins 0.000 description 1
- 102100030703 Interleukin-22 Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000008558 Osteophyte Diseases 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000947 anti-immunosuppressive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000000604 fetal stem cell Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229960002849 glucosamine sulfate Drugs 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 238000011540 hip replacement Methods 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 230000008407 joint function Effects 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000001565 modulated differential scanning calorimetry Methods 0.000 description 1
- 210000004985 myeloid-derived suppressor cell Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000013546 non-drug therapy Methods 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940124636 opioid drug Drugs 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000005222 synovial tissue Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW108109188 | 2019-03-18 | ||
| TW108109188A TWI722400B (zh) | 2019-03-18 | 2019-03-18 | 間質幹細胞之胞外泌體及其用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020152698A JP2020152698A (ja) | 2020-09-24 |
| JP2020152698A5 true JP2020152698A5 (https=) | 2023-10-20 |
| JP7547032B2 JP7547032B2 (ja) | 2024-09-09 |
Family
ID=72515022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019054780A Active JP7547032B2 (ja) | 2019-03-18 | 2019-03-22 | 間葉系幹細胞のエキソソームおよびその使用 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US12383580B2 (https=) |
| JP (1) | JP7547032B2 (https=) |
| TW (1) | TWI722400B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112336750A (zh) * | 2020-11-11 | 2021-02-09 | 中山大学附属第三医院 | 间充质干细胞源性小细胞外囊泡在制备治疗自身免疫性疾病药物中的应用 |
| KR20220068148A (ko) * | 2020-11-18 | 2022-05-25 | 주식회사 온코인사이트 | 역분화 줄기세포 유래 중간엽 줄기세포로부터 분리된 엑소좀의 제조방법 및 이의 용도 |
| CN112410292B (zh) * | 2020-11-19 | 2022-06-07 | 广东香雪干细胞再生医学科技有限公司 | 脐带间充质干细胞脂质囊泡体的制备方法及其在促进皮肤再生中的应用 |
| KR102424333B1 (ko) * | 2020-12-14 | 2022-07-22 | 조선대학교산학협력단 | 펩타이드를 이용하는 줄기세포 유래 고순도 세포외 소포체의 대량 생산 방법 |
| US20240139376A1 (en) * | 2021-02-12 | 2024-05-02 | Rhode Island Hospital | Reconstitution of extracellular matrixes for musculoskeletal joint tissue repair using biomimetic biologic and synthetic factors |
| CN113005093A (zh) * | 2021-02-25 | 2021-06-22 | 翟骁 | Cd73修饰的人脐带血来源的外泌体及其应用 |
| CN113321709A (zh) * | 2021-05-18 | 2021-08-31 | 南方医科大学 | 自组装多肽、缓释外泌体多肽水凝胶及其制备方法和应用 |
| CN113197919B (zh) * | 2021-05-27 | 2023-02-03 | 中国科学院动物研究所 | 鹿茸干细胞外泌体在制备改善或治疗骨关节炎和延缓细胞衰老的产品中的应用 |
| CN113616675A (zh) * | 2021-08-23 | 2021-11-09 | 上海太安堂生物医学有限公司 | 含间充质干细胞的组合物及其在治疗退行性关节炎的应用 |
| JP2024530288A (ja) * | 2021-08-24 | 2024-08-16 | フォーエバー・ラボラトリーズ・インコーポレイテッド | 細胞外小胞を単離するためのデバイス及び方法 |
| CN114377034A (zh) * | 2022-01-19 | 2022-04-22 | 四川大学华西医院 | 一种用于关节炎治疗的生物制剂及其制备方法和应用 |
| CN114591901B (zh) * | 2022-03-24 | 2023-11-24 | 和携科技有限公司 | 动物脐带间充质干细胞外泌体提取方法 |
| CN114939128A (zh) * | 2022-06-02 | 2022-08-26 | 尧舜泽生物医药(南京)有限公司 | 骨髓间充质干细胞外泌体在修复关节软骨缺损中的应用 |
| CN115068616A (zh) * | 2022-06-16 | 2022-09-20 | 广州惠善医疗技术有限公司 | 间充质干细胞来源外泌体联合非甾体抗炎药在制备预防或治疗骨关节疾病药物中的应用 |
| CN114891736A (zh) * | 2022-07-01 | 2022-08-12 | 中晶生物技术股份有限公司 | 一种三维培养的间充质干细胞外泌体增强软骨细胞生长与特性维持的方法及其应用 |
| CN115487208A (zh) * | 2022-10-24 | 2022-12-20 | 格莱康美生物医学技术(北京)有限公司 | 一种用于治疗骨关节炎/软骨损伤的组合物及其制备方法 |
| CN116115642A (zh) * | 2023-01-18 | 2023-05-16 | 北京美欧赛奥金生物科技有限公司 | 改良富血小板血浆制备及制剂组合物应用 |
| JPWO2024195878A1 (https=) * | 2023-03-23 | 2024-09-26 | ||
| US20240408237A1 (en) * | 2023-06-08 | 2024-12-12 | Far Eastern Memorial Hospital | Method and pharmaceutical composition for treating a cartilage damage using sox9 gene |
| CN116445401B (zh) * | 2023-06-14 | 2023-08-22 | 成都康景生物科技有限公司 | 间充质干细胞培养基、干细胞外泌体及制备方法 |
| KR102739922B1 (ko) * | 2024-02-22 | 2024-12-11 | 유한회사 스템메디케어 | 면역관용화된 태아 줄기세포 유래 세포외소포의 골관절염 치료용 약학조성물로서의 용도, 세포외소포 제조방법 및 이를 이용한 골관절염 치료용 조성물 |
| CN118165927A (zh) * | 2024-04-24 | 2024-06-11 | 广州汉密顿生物科技有限公司 | 一种人脐带间充质干细胞制剂、制备方法及其在治疗膝骨关节炎中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015038075A1 (en) * | 2013-09-16 | 2015-03-19 | Agency For Science, Technology And Research | Method |
| KR101706642B1 (ko) * | 2015-02-04 | 2017-02-17 | 주식회사 엑소스템텍 | 연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물 |
| JP6714932B2 (ja) | 2015-12-01 | 2020-07-01 | 株式会社ＡｄｉｐｏＳｅｅｄｓ | 脊椎動物の脂肪組織由来間葉系細胞株の製造方法 |
| EP3254684B1 (en) | 2016-06-08 | 2019-10-23 | Lysatpharma GmbH | Human platelet lysate or fraction enriched in human platelet-derived extracellular vesicles, for use in medicine |
| US10946047B2 (en) * | 2016-06-17 | 2021-03-16 | United Therapeutics Corporation | Extracellular vesicles with enhanced potency |
| CA3064064A1 (en) * | 2017-05-16 | 2018-11-22 | Exostem Biotec Ltd. | Methods of inhibiting aging and treating aging-related disorders |
-
2019
- 2019-03-18 TW TW108109188A patent/TWI722400B/zh active
- 2019-03-22 JP JP2019054780A patent/JP7547032B2/ja active Active
-
2020
- 2020-03-17 US US16/821,481 patent/US12383580B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020152698A5 (https=) | ||
| Kon et al. | Non-surgical management of early knee osteoarthritis | |
| Ayhan et al. | Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis | |
| KR100989109B1 (ko) | 골관절염 치료에 사용되는 나트륨 히알루로네이트 및콘드로이친 설페이트의 혼합물의 용도 | |
| JP2020152698A (ja) | 間葉系幹細胞のエキソソームおよびその使用 | |
| Shoukrie et al. | Safety and efficacy of injecting mesenchymal stem cells into a human knee joint to treat osteoarthritis: A systematic review | |
| Hegab et al. | Synergistic effect of platelet rich plasma with hyaluronic acid injection following arthrocentesis to reduce pain and improve function in TMJ osteoarthritis | |
| Rossi et al. | Glenohumeral osteoarthritis: the role for orthobiologic therapies: platelet-rich plasma and cell therapies | |
| Thakkar et al. | Infusion of autologous adipose tissue derived neuronal differentiated mesenchymal stem cells and hematopoietic stem cells in post-traumatic paraplegia offers a viable therapeutic approach | |
| Sharma et al. | A comparative analysis between intra articular injections of injectable platelet rich fibrin versus platelet rich plasma in the management of temporomandibular disorders: A randomized control trial | |
| Long et al. | The Effectiveness and Safety of Mesenchymal Stem Cells in the Treatment of Osteoarthritis: A Systematic Review and Meta‐analysis of 28 Randomized Controlled Trials | |
| CN107661501A (zh) | 一种治疗强直性脊柱炎的药物组合物、药物靶点及其应用 | |
| WO2021042275A1 (zh) | 一种治疗骨性关节炎的的中药组合物 | |
| Parra et al. | Autologous platelet concentrates as treatment for avascular necrosis of femoral head in a dog | |
| Liu et al. | Intra-articular injection of stromal vascular fraction for knee degenerative joint disease: a concise review of preclinical and clinical evidence | |
| CN115025121B (zh) | 一种复合细胞制剂及其制备方法与应用 | |
| Pak et al. | EῘcacy of autologous adipose tissue-derived stem cells with extracellular matrix and hyaluronic acid on human hip osteoarthritis | |
| ES2377993T3 (es) | Utilización de fracciones celulares del tejido adiposo para la regeneración tisular post-irradiación | |
| RU2519119C1 (ru) | Способ лечения дегенеративных и воспалительно-дегенеративных заболеваний суставов | |
| Aratikatla et al. | Gold-induced cytokine (GOLDIC) for the management of knee osteoarthritis: a systematic review | |
| Varma et al. | Single versus Three Doses of Intraarticular Platelet-Rich Plasma Injection in Treatment of Early Osteoarthritis Knee Joint—A Prospective Comparative Study | |
| Gunawan et al. | Platelet-rich plasma (PRP) on orthopedic clinical daily practice: a literature review | |
| Lee et al. | Intra-articular injections of platelet-rich plasma in patients with knee pain of articular cartilage origin (degenerative chondropathy and early OA) | |
| Ding | Cartilage of knee: anatomy, function and recent conservative treatments | |
| Primorac et al. | Mesenchymal stem cells in orthopedics-a current perspective |